# ASCEND CSP IDE Study

Study · id `cardio:ct-nct06830746` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06830746](<https://clinicaltrials.gov/study/NCT06830746>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT06830746

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 414 participants.

## Technical summary

Registry record NCT06830746. Allocation not applicable; no masking; primary purpose treatment. Start 2025-04-11 (actual); primary completion 2026-01-29 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 414 participants (planned count; ClinicalTrials.gov record NCT06830746, source copy `cardio:ctgov-nct06830746-2026-03-18`, retrieved 2026-10-26)
- Started: 2025-04-11 (actual) (ClinicalTrials.gov record NCT06830746, source copy `cardio:ctgov-nct06830746-2026-03-18`, retrieved 2026-10-26)
- Primary completion: 2026-01-29 (actual) (ClinicalTrials.gov record NCT06830746, source copy `cardio:ctgov-nct06830746-2026-03-18`, retrieved 2026-10-26)
- Completion: 2028-05 (anticipated) (ClinicalTrials.gov record NCT06830746, source copy `cardio:ctgov-nct06830746-2026-03-18`, retrieved 2026-10-26)
- Countries: United States; Australia; Canada; France; Hong Kong SAR China; India; Italy; Singapore; Spain; Switzerland (ClinicalTrials.gov record NCT06830746, source copy `cardio:ctgov-nct06830746-2026-03-18`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06830746-2026-03-18`, retrieved 2026-10-26)

## The registry's words

- Brief title: ASCEND CSP IDE Study
- Acronym: ASCEND CSP IDE
- Condition: Heart Failure
- Condition: Ventricular Arrythmia
- Intervention (Device): LBBAP Implant with a CSP ICD Lead
- Lead sponsor: Abbott Medical Devices
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart failure (`cardio:heart-failure`)
- Registry lists this organization as the lead sponsor: Abbott (`cardio:abbott`)

## Provenance

Content hash: acf2512382b36fddcc86f1a9e3a4031c481373a12cebebbb8798b19d1761e2eb
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
